Breast CancerNCT07549139
Overcoming Racial Disparities in Screening Mammography
A study testing Appointment mail reminder, Telephone counseling and Digital navigation video in people with Breast Cancer and Cancer of the Breast, run by Washington University School of Medicine at 1 site in United States.
Trial summary
The purpose of this study is to increase screening mammography among Black women by implementing and evaluating a culturally tailored patient-centric program designed to address barriers to screening. Read more about this study
- Who is it for?
- Ages 40 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Breast Cancer, Cancer of the Breast
- What is being tested?
- Appointment mail reminder, Telephone counseling and Digital navigation video
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 176 participants
- Where
- 1 siteUnited States
- Study dates
- 31 Oct 2026to 30 Apr 2028
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Woman
- At least 40 years old
- Self-identify as Black
- English-speaking
- Scheduled for a screening mammogram within 8 weeks of study entry
- Able to understand and willing to sign an IRB approved written informed consent document.
Who cannot join
- A previous history of breast cancer
- Scheduled for a diagnostic mammogram
- Has a documented or uncorrectable cognitive, hearing, or visual impairment.
- Too ill to participate (diagnosed with or suffering from a condition that, in the judgment of the investigator, may limit participation in the study).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Washington University School of Medicine
St Louis, Missouri, 63110
Foluso Ademuyiwa, MD, MPH, MSCI, 314-362-5654, bisiademuyiwa@wustl.edu
Foluso Ademuyiwa, MD, MPH, MSCI
About this study
Official title: A Personalized Approach to Promote Health Equity by Overcoming Racial Disparities in Screening Mammography
The purpose of this study is to increase screening mammography among Black women by implementing and evaluating a culturally tailored patient-centric program designed to address barriers to screening. By performing a randomized clinical trial, this study aims to develop effective strategies to improve adherence to screening mammography and contribute to reducing health disparities in breast cancer outcomes.
- Conditions
- Breast Cancer, Cancer of the Breast
- Being tested
- Appointment mail reminder, Telephone counseling, Digital navigation video, Automated phone call
- Keywords
- Breast cancer screening, Mammography, Black women, Disparities, No-show rates
- Medical subject headings
- Breast Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Appointment mail reminderOther
Patient will receive an appointment reminder in the mail 7-10 days prior to the appointment.
Telephone counselingOther
The telephone counseling will include an appointment reminder within 7 days of their appointment and identify and troubleshoot barriers to patient's mammography completion.
Digital navigation videoOther
The digital navigation video will explain the rationale for the mammogram and the mammography procedure. Digital navigation video will be sent by SMS text message 1-3 days prior to the appointment.
Automated phone callOther
Patient will receive an automated reminder phone call for their appointment 1-3 days prior to the appointment.
| Study group | Role | What they receive |
|---|---|---|
| Arm 1: Usual Care | Active comparator | Patients will receive the institution's usual care for screening mammogram, which consists of an automated reminder phone call from the breast health center 1-3 days prior to a scheduled appointment. Receives: Other: Automated phone call |
| Arm 2: Culturally Tailored Patient Centric Program Methods | Experimental | Patients will receive mail reminders at 7-10 days prior to appointment, tailored telephone counseling to both serve as an appointment reminder and to identify and troubleshoot salient barriers to mammography completion, and a digital navigation video explaining the rationale for and the actual mammography procedure. All study procedures are carried out remotely with no additional research visits for participants. Receives: Other: Appointment mail reminder; Other: Telephone counseling; Other: Digital navigation video |
What is being measured
The primary outcome is the main question the study is designed to answer.
No-show rate
Defined as the proportion of participants who do not complete (or do not reschedule) their screening mammogram appointment within 6 months of randomization.
Measured: 6 months after randomization
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Apr 2026
- Study start31 Oct 2026 (estimated)
- Primary completion30 Apr 2028 (estimated)
- Study completion30 Apr 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- More trials run by Washington University School of MedicineThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 176 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Washington University School of Medicine
- Sponsor type
- University, hospital or other
- Collaborators
- National Comprehensive Cancer Network, Novartis
- Responsible party
- Sponsor
- Investigators
- Foluso Ademuyiwa, MD, MPH, MSCI, Principal investigator, Washington University School of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07549139
- Sponsor's protocol ID
- 202604048
- Status last verified
- Aug 2026
- First submitted
- 17 Apr 2026
- Last updated
- 12 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No